Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss

View through CrossRef
ABSTRACT Introduction Finasteride has been associated with reversible adverse sexual side effects in multiple randomized, controlled trials for the treatment of male pattern hair loss (MPHL). The Medicines and Healthcare Products Regulatory Agency of the United Kingdom and the Swedish Medical Products Agency have both updated their patient information leaflets to include a statement that “persistence of erectile dysfunction after discontinuation of treatment with Propecia has been reported in post-marketing use.” Aim We sought to characterize the types and duration of persistent sexual side effects in otherwise healthy men who took finasteride for MPHL. Methods We conducted standardized interviews with 71 otherwise healthy men aged 21–46 years who reported the new onset of sexual side effects associated with the temporal use of finasteride, in which the symptoms persisted for at least 3 months despite the discontinuation of finasteride. Main Outcome Measures The types and duration of sexual dysfunction and the changes in perceived sexual frequency and sexual dysfunction score between pre- and post-finasteride use. Results Subjects reported new-onset persistent sexual dysfunction associated with the use of finasteride: 94% developed low libido, 92% developed erectile dysfunction, 92% developed decreased arousal, and 69% developed problems with orgasm. The mean number of sexual episodes per month dropped and the total sexual dysfunction score increased for before and after finasteride use according to the Arizona Sexual Experience Scale (P <0.0001 for both). The mean duration of finasteride use was 28 months and the mean duration of persistent sexual side effects was 40 months from the time of finasteride cessation to the interview date. Study limitations include a post hoc approach, selection bias, recall bias for before finasteride data, and no serum hormone levels. Conclusion Physicians treating MPHL should discuss the potential risk of persistent sexual side effects associated with finasteride.
Title: Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss
Description:
ABSTRACT Introduction Finasteride has been associated with reversible adverse sexual side effects in multiple randomized, controlled trials for the treatment of male pattern hair loss (MPHL).
The Medicines and Healthcare Products Regulatory Agency of the United Kingdom and the Swedish Medical Products Agency have both updated their patient information leaflets to include a statement that “persistence of erectile dysfunction after discontinuation of treatment with Propecia has been reported in post-marketing use.
” Aim We sought to characterize the types and duration of persistent sexual side effects in otherwise healthy men who took finasteride for MPHL.
Methods We conducted standardized interviews with 71 otherwise healthy men aged 21–46 years who reported the new onset of sexual side effects associated with the temporal use of finasteride, in which the symptoms persisted for at least 3 months despite the discontinuation of finasteride.
Main Outcome Measures The types and duration of sexual dysfunction and the changes in perceived sexual frequency and sexual dysfunction score between pre- and post-finasteride use.
Results Subjects reported new-onset persistent sexual dysfunction associated with the use of finasteride: 94% developed low libido, 92% developed erectile dysfunction, 92% developed decreased arousal, and 69% developed problems with orgasm.
The mean number of sexual episodes per month dropped and the total sexual dysfunction score increased for before and after finasteride use according to the Arizona Sexual Experience Scale (P <0.
0001 for both).
The mean duration of finasteride use was 28 months and the mean duration of persistent sexual side effects was 40 months from the time of finasteride cessation to the interview date.
Study limitations include a post hoc approach, selection bias, recall bias for before finasteride data, and no serum hormone levels.
Conclusion Physicians treating MPHL should discuss the potential risk of persistent sexual side effects associated with finasteride.

Related Results

Persistent Sexual Side Effects of Finasteride: Could They be Permanent?
Persistent Sexual Side Effects of Finasteride: Could They be Permanent?
ABSTRACT Introduction Finasteride has been associated with sexual side effects that may persist despite discontinuation of the m...
Global Online Interest in Finasteride Sexual Side Effects
Global Online Interest in Finasteride Sexual Side Effects
Abstract Prior literature has suggested that Propecia or finasteride may negatively impact men’s sexual health. In 2011, the Food and Drug Administration (FDA) provided a w...
Finasteride and Suicide: A Postmarketing Case Series
Finasteride and Suicide: A Postmarketing Case Series
<b><i>Background:</i></b> In 2011, depression was added to the product labeling of finasteride in the USA. The US Food and Drug Administration’s Adverse Eve...
clinical trial efficacy of autologous cellular micrografts in androgenic alopecia
clinical trial efficacy of autologous cellular micrografts in androgenic alopecia
Abstract Purpose: Autologous cellular micrografts (ACM) is a novel treatment method in hair loss and androgenic alopecia. Androgenetic alopecia, androgenic alopecia, patter...
Effects on Oral Supplementation of Nutraceuticals formulations - Trichovitals® in young adults for healthy maintenance of hair growth
Effects on Oral Supplementation of Nutraceuticals formulations - Trichovitals® in young adults for healthy maintenance of hair growth
Nutrition is a major factor in affecting the health and appearance of hair. In addition to how one eats dietary supplementation plays very critical role in overall maintenance of h...
Altered Skin Permeation of Finasteride Using Clove Oil, Urea, and Lyophilized Powder of Grape Seed Extract
Altered Skin Permeation of Finasteride Using Clove Oil, Urea, and Lyophilized Powder of Grape Seed Extract
Purpose: Finasteride is a 5-alpha reductase inhibitor used to treat hair loss and acne. The skin permeation of finasteride is one of the main challenges associated with dermal drug...

Back to Top